Global Market Report

Global Neurological Disorder Drugs Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Nov 11, 2018
  • PAGES：182
  • REPORT CODE：GMM124259
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Neurological Disorder Drugs witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Neurological Disorder Drugs market is offered. The research provides insights for the global Neurological Disorder Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Neurological Disorder Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Neurological Disorder Drugs Market Segmentations:

    By Players:

    • AstraZeneca

    • Merck & Co.

    • Teva Pharmaceutical Industries Ltd.

    • F. Hoffmann-La Roche Ltd.

    • GlaxoSmithKline plc

    • Novartis AG

    • Boehringer Ingelheim GmbH

    • Bayer AG


    By Types:

    • Antipsychotic

    • Hypnotic & Sedative

    • Analgesics

    • Anticoagulants

    • Others


    By End-User:

    • Hospital

    • Clinic

    • Home


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Neurological Disorder Drugs Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Neurological Disorder Drugs Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Disorder Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Neurological Disorder Drugs Market Share by Types

      • 1.3.2 Global Neurological Disorder Drugs Market Size and Growth Rate of Antipsychotic from 2013 to 2025

      • 1.3.3 Global Neurological Disorder Drugs Market Size and Growth Rate of Hypnotic & Sedative from 2013 to 2025

      • 1.3.4 Global Neurological Disorder Drugs Market Size and Growth Rate of Analgesics from 2013 to 2025

      • 1.3.5 Global Neurological Disorder Drugs Market Size and Growth Rate of Anticoagulants from 2013 to 2025

      • 1.3.6 Global Neurological Disorder Drugs Market Size and Growth Rate of Others from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Neurological Disorder Drugs Market Share by End-Users

      • 1.4.2 Global Neurological Disorder Drugs Market Size and Growth Rate of Hospital from 2013 to 2025

      • 1.4.3 Global Neurological Disorder Drugs Market Size and Growth Rate of Clinic from 2013 to 2025

      • 1.4.4 Global Neurological Disorder Drugs Market Size and Growth Rate of Home from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumNeurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Neurological Disorder Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurological Disorder Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Antipsychotic

      • 3.4.2 Market Size and Growth Rate of Hypnotic & Sedative

      • 3.4.3 Market Size and Growth Rate of Analgesics

      • 3.4.4 Market Size and Growth Rate of Anticoagulants

      • 3.4.5 Market Size and Growth Rate of Others


    4 Segmentation of Neurological Disorder Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurological Disorder Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurological Disorder Drugs for Hospital

      • 4.4.2 Market Size and Growth Rate of Neurological Disorder Drugs for Clinic

      • 4.4.3 Market Size and Growth Rate of Neurological Disorder Drugs for Home


    5 Market Analysis by Major Regions

    • 5.1 Global Neurological Disorder Drugs Production Analysis by Major Regions

    • 5.2 Global Neurological Disorder Drugs Consumption Analysis by Major Regions

    • 5.3 Global Neurological Disorder Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Neurological Disorder Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Neurological Disorder Drugs Production, Import, Consumption and Export Analysis


    6 Product Commodity of Neurological Disorder Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Neurological Disorder Drugs market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Neurological Disorder Drugs market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Neurological Disorder Drugs market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Neurological Disorder Drugs market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Neurological Disorder Drugs Landscape Analysis

    • 7.1 North America Neurological Disorder Drugs Landscape Analysis by Major Types

    • 7.2 North America Neurological Disorder Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Neurological Disorder Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Neurological Disorder Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Neurological Disorder Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Neurological Disorder Drugs Market Volume and Growth Rate


    8 Europe Neurological Disorder Drugs Landscape Analysis

    • 8.1 Europe Neurological Disorder Drugs Landscape Analysis by Major Types

    • 8.2 Europe Neurological Disorder Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Neurological Disorder Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.2 UK Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.3 France Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Neurological Disorder Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Neurological Disorder Drugs Market Volume and Growth Rate


    9 Asia Pacific Neurological Disorder Drugs Landscape Analysis

    • 9.1 Asia Pacific Neurological Disorder Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Neurological Disorder Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Neurological Disorder Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Neurological Disorder Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Neurological Disorder Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Neurological Disorder Drugs Market Volume and Growth Rate

      • 9.3.4 India Neurological Disorder Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Neurological Disorder Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Neurological Disorder Drugs Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Neurological Disorder Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Neurological Disorder Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Neurological Disorder Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Neurological Disorder Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Neurological Disorder Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Neurological Disorder Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Neurological Disorder Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Neurological Disorder Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Neurological Disorder Drugs Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 AstraZeneca

      • 11.1.1 AstraZeneca Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Merck & Co.

      • 11.2.1 Merck & Co. Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Teva Pharmaceutical Industries Ltd.

      • 11.3.1 Teva Pharmaceutical Industries Ltd. Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 F. Hoffmann-La Roche Ltd.

      • 11.4.1 F. Hoffmann-La Roche Ltd. Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 GlaxoSmithKline plc

      • 11.5.1 GlaxoSmithKline plc Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Novartis AG

      • 11.6.1 Novartis AG Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Boehringer Ingelheim GmbH

      • 11.7.1 Boehringer Ingelheim GmbH Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Bayer AG

      • 11.8.1 Bayer AG Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 80 Figures and 145 Tables)

    • Figure Product Picture

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Antipsychotic from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Hypnotic & Sedative from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Analgesics from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Anticoagulants from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Others from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Hospital from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Clinic from 2013 to 2025

    • Figure Global Neurological Disorder Drugs Market Size and Growth Rate of Home from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Neurological Disorder Drugs Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Neurological Disorder Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neurological Disorder Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurological Disorder Drugs by Different Types from 2013 to 2025

    • Table Consumption Share of Neurological Disorder Drugs by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Antipsychotic

    • Figure Market Size and Growth Rate of Hypnotic & Sedative

    • Figure Market Size and Growth Rate of Analgesics

    • Figure Market Size and Growth Rate of Anticoagulants

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neurological Disorder Drugs by Different End-Users from 2013 to 2025

    • Table Consumption Share of Neurological Disorder Drugs by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Home

    • Table Global Neurological Disorder Drugs Production by Major Regions

    • Table Global Neurological Disorder Drugs Production Share by Major Regions

    • Figure Global Neurological Disorder Drugs Production Share by Major Regions in 2013

    • Figure Global Neurological Disorder Drugs Production Share by Major Regions in 2018

    • Figure Global Neurological Disorder Drugs Production Share by Major Regions in 2025

    • Table Global Neurological Disorder Drugs Consumption by Major Regions

    • Table Global Neurological Disorder Drugs Consumption Share by Major Regions

    • Figure Global Neurological Disorder Drugs Consumption Share by Major Regions in 2013

    • Figure Global Neurological Disorder Drugs Consumption Share by Major Regions in 2018

    • Figure Global Neurological Disorder Drugs Consumption Share by Major Regions in 2025

    • Table North America Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Neurological Disorder Drugs market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Neurological Disorder Drugs Consumption by Types from 2013 to 2025

    • Table North America Neurological Disorder Drugs Consumption Share by Types from 2013 to 2025

    • Figure North America Neurological Disorder Drugs Consumption Share by Types in 2013

    • Figure North America Neurological Disorder Drugs Consumption Share by Types in 2018

    • Figure North America Neurological Disorder Drugs Consumption Share by Types in 2025

    • Table North America Neurological Disorder Drugs Consumption by End-Users from 2013 to 2025

    • Table North America Neurological Disorder Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure North America Neurological Disorder Drugs Consumption Share by End-Users in 2013

    • Figure North America Neurological Disorder Drugs Consumption Share by End-Users in 2018

    • Figure North America Neurological Disorder Drugs Consumption Share by End-Users in 2025

    • Table North America Neurological Disorder Drugs Consumption by Major Countries from 2013 to 2025

    • Table North America Neurological Disorder Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Neurological Disorder Drugs Consumption Share by Major Countries in 2013

    • Figure North America Neurological Disorder Drugs Consumption Share by Major Countries in 2018

    • Figure North America Neurological Disorder Drugs Consumption Share by Major Countries in 2025

    • Figure United States Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Neurological Disorder Drugs Consumption by Types from 2013 to 2025

    • Table Europe Neurological Disorder Drugs Consumption Share by Types from 2013 to 2025

    • Figure Europe Neurological Disorder Drugs Consumption Share by Types in 2013

    • Figure Europe Neurological Disorder Drugs Consumption Share by Types in 2018

    • Figure Europe Neurological Disorder Drugs Consumption Share by Types in 2025

    • Table Europe Neurological Disorder Drugs Consumption by End-Users from 2013 to 2025

    • Table Europe Neurological Disorder Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Neurological Disorder Drugs Consumption Share by End-Users in 2013

    • Figure Europe Neurological Disorder Drugs Consumption Share by End-Users in 2018

    • Figure Europe Neurological Disorder Drugs Consumption Share by End-Users in 2025

    • Table Europe Neurological Disorder Drugs Consumption by Major Countries from 2013 to 2025

    • Table Europe Neurological Disorder Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Neurological Disorder Drugs Consumption Share by Major Countries in 2013

    • Figure Europe Neurological Disorder Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Neurological Disorder Drugs Consumption Share by Major Countries in 2025

    • Figure Germany Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure France Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption by Types from 2013 to 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Types in 2013

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Types in 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by End-Users in 2013

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by End-Users in 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Neurological Disorder Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Neurological Disorder Drugs Consumption Share by Major Countries in 2025

    • Figure China Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandNeurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure India Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Neurological Disorder Drugs Consumption Share by Major Countries in 2025

    • Figure GCC Countries Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Neurological Disorder Drugs Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Merck & Co.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co.

    • Figure Sales and Growth Rate Analysis of Merck & Co.

    • Figure Revenue and Market Share Analysis of Merck & Co.

    • Table Product and Service Introduction of Merck & Co.

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd.

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd.

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd.

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd.

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd.

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Boehringer Ingelheim GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH

    • Table Product and Service Introduction of Boehringer Ingelheim GmbH

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US